Compare BRAG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRAG | NTRB |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | Canada | United States |
| Employees | N/A | 3 |
| Industry | Office Equipment/Supplies/Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 42.4M |
| IPO Year | 2021 | N/A |
| Metric | BRAG | NTRB |
|---|---|---|
| Price | $1.60 | $3.53 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 45.2K | 8.7K |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $6.67 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.42 | $3.21 |
| 52 Week High | $4.78 | $11.68 |
| Indicator | BRAG | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 38.98 | 48.07 |
| Support Level | $1.45 | $3.44 |
| Resistance Level | $2.23 | $3.69 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 29.96 | 79.21 |
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from Malta, and the rest from Netherlands, Curacao, the United States, Croatia, Marshall Islands, Brazil, Isle of Man, Belgium, Czech Republic, and other regions.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.